Literature DB >> 8856029

Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.

T Yamaguchi1, K Iwata, M Kobayashi, M Ogawa, H Fukushi, K Hirai.   

Abstract

Twenty hybridoma cell lines producing monoclonal antibodies (MAbs) against serotype 1 infectious bursal disease virus (IBDV) of GBF-1 and the attenuated GBF-1E strains were produced. The MAbs recognized major structural proteins VP2 and VP3. MAb recognition sites were mapped using recombinant Escherichia coli clones which expressed N-terminal and (or) C-terminal truncated virus antigens, and competitive-binding assays. At least 3 conformation-dependent serotype 1 specific virus neutralizing antigenic sites and a linear antigenic site were defined on VP2 and VP3, respectively. Two of the conformational virus neutralizing antigenic sites were localized in the central area of VP2 consisting of 156 amino acid residues, and the linear epitope was localized in C-terminal 105 amino acid residues of VP3. Another conformational virus neutralizing antigenic site recognized with the virus neutralizing MAb GK-5 was not defined because GK-5 did not react with virus antigen expressed in recombinant E. coli. The conformational antigenic site was supposed to be composed of tertiary or quaternary protein structure, which may not be constructed in recombinant E. coli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856029     DOI: 10.1007/bf01718250

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

Review 1.  Immunosuppression induced by infectious bursal disease virus.

Authors:  Y M Saif
Journal:  Vet Immunol Immunopathol       Date:  1991-11       Impact factor: 2.046

2.  Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus.

Authors:  A A Azad; M N Jagadish; M A Brown; P J Hudson
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Localization of a VP3 epitope of infectious bursal disease virus.

Authors:  M N Jagadish; A A Azad
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

5.  Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus.

Authors:  V Oppling; H Müller; H Becht
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Genomic structure of the large RNA segment of infectious bursal disease virus.

Authors:  P J Hudson; N M McKern; B E Power; A A Azad
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

7.  Characteristics and serologic studies of two serotypes of infectious bursal disease virus in turkeys.

Authors:  D J Jackwood; Y M Saif; J H Hughes
Journal:  Avian Dis       Date:  1982 Oct-Dec       Impact factor: 1.577

8.  Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains.

Authors:  H G Heine; M Haritou; P Failla; K Fahey; A Azad
Journal:  J Gen Virol       Date:  1991-08       Impact factor: 3.891

9.  The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus.

Authors:  A A Azad; S A Barrett; K J Fahey
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype.

Authors:  J B McFerran; M S McNulty; E R McKillop; T J Connor; R M McCracken; D S Collins; G M Allan
Journal:  Avian Pathol       Date:  1980-07       Impact factor: 3.378

View more
  8 in total

1.  Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Changes in VP3 and VP5 genes during the attenuation of the very virulent infectious bursal disease virus strain Gx isolated in China.

Authors:  Xiaomei Wang; Houshuang Zhang; Honglei Gao; Chaoyang Fu; Yulong Gao; Yulin Ju
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

3.  Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure.

Authors:  Hein J Boot; A Agnes H M ter Huurne; Arjan J W Hoekman; Jan M Pol; Arno L J Gielkens; Ben P H Peeters
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Detection of infectious bursal disease virus (IBDV) genome in free-living pigeon and guinea fowl in Africa suggests involvement of wild birds in the epidemiology of IBDV.

Authors:  Christopher J Kasanga; Tsuyoshi Yamaguchi; Philemon N Wambura; Hetron M Munang'andu; Kenji Ohya; Hideto Fukushi
Journal:  Virus Genes       Date:  2008-03-15       Impact factor: 2.332

5.  Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors.

Authors:  Juan Martin Caballero; Ana Garzón; Leticia González-Cintado; Wioleta Kowalczyk; Ignacio Jimenez Torres; Gloria Calderita; Margarita Rodriguez; Virgínia Gondar; Juan Jose Bernal; Carlos Ardavín; David Andreu; Thomas Zürcher; Cayetano von Kobbe
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

6.  Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.

Authors:  Fang He; Tanja K Kiener; Xiao Fang Lim; Yunrui Tan; Kattur Venkatachalam Ashok Raj; Manli Tang; Vincent T K Chow; Qingfeng Chen; Jimmy Kwang
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

7.  Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4.

Authors:  Hyun-Jeong Lee; Ji-Ye Kim; Soo-Jeong Kye; Hee-Jung Seul; Suk-Chan Jung; Kang-Seuk Choi
Journal:  Virol J       Date:  2015-10-26       Impact factor: 4.099

8.  Assessing the antigenicity of different VP3 regions of infectious bursal disease virus in chickens from South Brazil.

Authors:  Ana Paula Gori Palka; Tatiana Reichert Assunção de Matos; Claudemir de Souza; Danilo Santos Eugênio; Marco Aurélio Krieger; Stenio Perdigão Fragoso; Daniela Parada Pavoni
Journal:  BMC Vet Res       Date:  2021-07-30       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.